Collegium Pharmaceutical, Inc SEC filings COLL
Collegium Pharmaceutical, Inc has 870 filings in SEC EDGAR's recent list, going back to Oct 20, 2003. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-T/A | Filing | Mar 21, 2022 | — |
| SC TO-T/A | Filing | Mar 11, 2022 | — |
| SC TO-T/A | Filing | Mar 4, 2022 | — |
| SC TO-T/A | Filing | Feb 22, 2022 | — |
| SC TO-T | Filing | Feb 18, 2022 | — |
| SC TO-C | Filing | Feb 14, 2022 | — |
| EFFECT | Filing | Mar 30, 2020 | — |
| CORRESP | Letter to the SEC | Mar 27, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2020 | — |
| 305B2 | Filing | Feb 11, 2020 | — |
| EFFECT | Filing | Nov 6, 2019 | — |
| CORRESP | Letter to the SEC | Nov 1, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2019 | — |
| D | Filing | Nov 13, 2018 | — |
| CT ORDER | Filing | Apr 18, 2018 | — |
| EFFECT | Filing | Oct 18, 2016 | — |
| CORRESP | Letter to the SEC | Oct 14, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2016 | — |
| CT ORDER | Filing | Sep 27, 2016 | — |
| EFFECT | Filing | Jan 7, 2016 | — |
| CORRESP | Letter to the SEC | Jan 5, 2016 | — |
| CORRESP | Letter to the SEC | Jan 5, 2016 | — |
| CORRESP | Letter to the SEC | Jan 4, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2015 | — |
| EFFECT | Filing | May 6, 2015 | — |
| CERTNAS | Auto-generated paper document | May 5, 2015 | — |
| CORRESP | Letter to the SEC | May 4, 2015 | — |
| CORRESP | Letter to the SEC | May 4, 2015 | — |
| CORRESP | Letter to the SEC | May 4, 2015 | — |
| 8-A12B | Filing | May 1, 2015 | — |
| CORRESP | Letter to the SEC | Apr 22, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2015 | — |
| D | Filing | Mar 13, 2015 | — |
| DRSLTR | Filing | Mar 3, 2015 | — |
| DRS | Filing | Mar 3, 2015 | — |
| D | Filing | Oct 2, 2013 | — |
| D | Filing | Feb 24, 2012 | — |
| D | Filing | Mar 8, 2010 | — |
| REGDEX | Auto-generated paper document | Jul 1, 2008 | — |
| REGDEX | Auto-generated paper document | Nov 13, 2007 | — |
| REGDEX | Auto-generated paper document | Jun 25, 2007 | — |
| REGDEX | Auto-generated paper document | Oct 19, 2006 | — |
| REGDEX | Auto-generated paper document | Apr 29, 2005 | — |
| REGDEX | Auto-generated paper document | Oct 20, 2003 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COLL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Stoughton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1267565
- Former names
- COLLEGIUM PHARMACEUTICAL INC (until Mar 3, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.